Results 161 to 170 of about 63,084 (277)

EE234 Economic Impact of Bimekizumab for Psoriatic Arthritis and Axial Spondyloarthritis in France [PDF]

Gérard de Pouvourville, Esteban Roig Fabré, T. Schleret, S. Leproust, B. Chabani, N Lyris, D. Willems, Phillip McCarthy, P Goupille   +8 more
openalex   +1 more source

Th17 and Interleukin 23 in the Pathogenesis of Psoriatic Arthritis and Spondyloarthritis [PDF]

, 2012
Alberto Cauli, Alessandro Mathieu
openalex   +1 more source

Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE). [PDF]

RMD Open
Vladimirova N, Østergaard M, Seven S, Møller JM, Jensen B, Østgård R, Poggenborg R, Madsen OR, Hendricks O, Brix L, Georgiadis S, Pedersen SJ.   +11 more
europepmc   +1 more source

Temporomandibular disorders and axial spondyloarthritis: How to manage this puzzle? [PDF]

Guilherme Azario de Holanda, Daniel Brito de Araújo, Maísa Casarin   +2 more
openalex   +1 more source

Validation of the Dudley inflammatory bowel symptom questionnaire for assessing gastrointestinal symptom burden in axial spondyloarthritis. [PDF]

Rheumatol Int
Ozoglu M, Temiz Karadag D, Gokcen N, Ozdemir Isik O, Yilmaz H, Cefle A, Yazici A.   +6 more
europepmc   +1 more source

AB0838 The efficacy of adalimumab and sulfasalazine in alleviating axial and aortic inflammation detected in pet/ct in patients with axial spondyloarthritis [PDF]

, 2018
Juha‐Pekka Kaijasilta, Anne M Kerola, Riitta Tuompo, Markku Kauppi, Heikki Relas, Antti Loimaala, H. Koivu, Jukka Schildt, Tuomas Kerola, Kari K. Eklund, Tuomo Nieminen   +10 more
openalex   +1 more source

Reducing selection bias while maintaining precision through an integrated analysis: 2-year longitudinal analysis of imaging outcomes in the SPondyloArthritis Caught Early cohort. [PDF]

RMD Open
de Bruin LJE, van Gaalen FA, de Hooge M, van Lunteren M, Marques ML, Reijnierse M, Ramonda R, Berg IJ, Turesson C, Landewé R, van der Heijde D, Ramiro S.   +11 more
europepmc   +1 more source

Disease Characteristics, Co-Morbidities and Treatment Response in a Contemporary Axial Spondyloarthritis Cohort: Analysis of 717 Patients from the Greek Axspa Registry

Charalampos Papagoras, G. Fragoulis, Nikolaos Fytanidis, Michael Krikelis, Evangelia Mole, Souzana Gazi, Vasileios Skepastianos, Nikolaos Kougkas, Theodoros Dimitroulas, Nikolaos Koletsos, Evripidis Kaltsonoudis, Paraskevi Voulgari, Αναστάσιος Καραμανάκος, Μαρία Παππά, Maria G. Tektonidou, Petros P. Sfikakis, Kalliopi Klavdianou, Eleni Kalavri, Konstantinos Kottas, Gikas Katsifis, Maria Konsta, E. Grika, Charalampos Sfontouris, Evgenia Mavrea, Christos Koutsianas, Evangelia Kataxaki, Eleni Sampatakaki, Konstantina Zoupidou, P. Katsimpri, Alexios Iliopoulos, Georgios Iliopoulos, Dimitrios Daoussis, Ilias Bournazos, Dimitrios Karokis, Dimos Patrikos, Dimitrios Vasilopoulos   +35 more
openalex   +1 more source

SAT0386 Extreme patient reported outcome (PRO) in early spondyloarthritis: a surrogate for fibromyalgia? its impact on TNF-ALPHA blockers treatment effect? [PDF]

, 2017
Bhowmik Meghnathi, Adrien Etcheto, Pascal Claudepierre, M Dougados, Anna Moltó   +4 more
openalex   +1 more source

Remote personalised exercise in axial spondyloarthritis: the SPARK trial - protocol for a 6-month randomised controlled trial. [PDF]

BMJ Open
Nellemann B, Fongen C, Dagfinrud H, Berg IJ, Kristianslund EK, Sexton J, Nordén KR, Lillegraven S, Østerås N, Jørgensen TS, Carmona L, Sveaas SH, Provan SA.   +12 more
europepmc   +1 more source